Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients

• Published in: Jundishapur journal of microbiology Vol. 8; no. 10; p. e26514
• Main Authors: Gurbuz, Yunus, Ozturk, Baris, Tutuncu, Emin Ediz, Sencan, Irfan, Cicek Senturk, Gonul, Altay, Fatma Aybala
• Format: Journal Article
• Language: English
• Published: Iran Ahvaz Jundishapur University of Medical Sciences 01.10.2015; Kowsar
• Subjects: Crimean-Congo Hemorrhagic Fever; Tissue Plasminogen Activator; Plasminogen Activator Inhibitor-1
• ISSN: 2008-3645; 2008-4161
• DOI: 10.5812/jjm.26514

Crimean-Congo hemorrhagic fever (CCHF) is a widespread disease in Turkey, and was responsible for many deaths in endemic regions during the last decade. The pathogenesis of the disease is not fully understood yet. In this study we aimed to determine the levels of tissue plasminogen activator (tPA) and Plasminogen activator inhibitor-1 (PAI-1) as predictors of prognosis in CCHF. Patients who were diagnosed by the polymerase chain reaction (PCR) and IgM positivity in the reference laboratory were included in this study. Tissue Plasminogen activator and PAI-1 levels were measured by the enzyme linked immunosorbent assay (ELISA) using a commercial kit (human t-PA ELISA and human PAL-1 ELISA; BioVendor research and diagnostic products, BioVendor-Laboratorni medicina a.s., Brno, Czech Republic). A total of 46 patients participated in this study. The significant differences between recovering patients and the patients who died, regarding Aspartate aminotransferase (AST), Creatine Phosphokinase (CPK), Lactate Dehydrogenase (LDH), Prothrombin Time (PT), activated Partial Thromboplastin time (aPTT), and thrombocyte and fibrinogen levels, were consistent with many clinical studies in the literature. The fatal cases were found to have higher tPA and PAI-1 levels in contrast to the patients who completely recovered. We think that these findings may help the progress of understanding of CCHF pathogenesis.